Advanced Services


Stoma appliance customisation service (SAC)

 

 

 

 

Appliance use review service (AURs)

These two services were introduced in April 2010 and they can be provided by both community pharmacy contractors and dispensing appliance contractors. 

The service involves the customisation of a quantity of more than one stoma appliance, based on the patient’s measurements or a template. The aim of the service is to ensure proper use and comfortable fitting of the stoma appliance and to improve the duration of usage, thereby reducing waste. The stoma appliances that can be customised are listed in Part IXC of the Drug Tariff. If a pharmacy intends to provide the SAC service the pharmacy must in the first instance notify Local NHS NHS England team and NHSBSA by completing the forms HERE

Appliance Use Reviews (AURs) can be carried out by a pharmacist or a specialist nurse in the pharmacy or at the patient’s home. AURs aim to improve the patient’s knowledge and use of their
appliances. If a pharmacy intends to provide the SAC service the pharmacy must in the first instance notify Local NHS NHS England team and NHSBSA by completing the forms HERE

Pharmacy Collect C-19 lateral flow device distribution service

 

 

 

 

This service aims to improve access to COVID-19 testing by making lateral flow device (LFD) test kits readily available at community pharmacies for asymptomatic people to collect. This enables identification of COVID-positive cases in the community and breaks the chain of transmission. Updates on changes to the service specification that will be introduced on 4th October 2021 can be found here.
Community pharmacist
consultation service (CPCS) Read more  
 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The NHS Community Pharmacist Consultation Service launched on 29th October 2019 as an Advanced Service. Since 1st November 2020, general practices have been able to refer patients for a minor illness consultation via CPCS, once a local referral pathway has been agreed.

The service will help to tackle elements of existing health inequalities by providing urgent access to patients who are not registered with a GP and will support the following:

  • To support the integration of community pharmacy into the urgent care system, and to divert patients with lower acuity conditions or who require urgent prescriptions, releasing capacity in other areas of the urgent care system.
  • To offer patients who contact NHS 111 the opportunity to access appropriate urgent care services in a convenient and easily accessible community pharmacy setting on referral from an NHS 111 call advisor and via the NHS 111 Online service.
  • To reduce demand on integrated urgent care services, urgent treatment centers, Emergency Departments, walk in centers, other primary care urgent care services and GP Out of Hours (OOH) services, and free up capacity for the treatment of patients with higher acuity conditions within these settings.
  • To appropriately manage patient requests for urgent supply of medicines and appliances.
  • To enable convenient and easy access for patients and for NHS 111 call advisor referral.
  • To reduce the use of primary medical services for the referral of low acuity conditions from NHS 111 and the need to generate urgent prescriptions.
  • To identify ways that individual patients can self-manage their health more effectively with the support of community pharmacists and to recommend solutions that could prevent use of Urgent and Emergency Care services in the
    future.
  • To ensure equity of access to the emergency supply provision, regardless of the patient’s ability to pay for the cost of the medicine or appliance requested.
  • To increase patient awareness of the role of community pharmacy as the ‘first port of call’ for low acuity conditions and for medicines access and advice.
    To be cost effective for the NHS when supporting patients with low acuity conditions

The table on the link below sets out the range of scenarios associated with the Community Pharmacist Consultation Service (CPCS) and when a consultation within the service is complete (and hence can be included in the total number of completed CPCS claimed at the end of the month on the FP34c).

Guidance on when a CPCS is complete here.

Tips for preparing for GP CPCS

  1. Reading the updated NHS CPCS Toolkit for pharmacy staff, so you understand more about how the pathway will operate.
  2. Reading the updated service specification;
  3. Briefing relevant staff on the changes to CPCS.
  4. Ensuring pharmacists that will provide the service read the updated toolkit and service specification.
  5. Support for pharmacists to reflect on continuing professional development activity they could undertake to provide the best possible service to patients, which could include undertaking the NHS-funded CPCS training provided by the Royal Pharmaceutical Society and the Royal College of General Practitioners or additional CPPE modules.
  6. Watch the GP CPCS webinar hosted by CPSS- GP-CPCS Webinar.

More information for all pharmacies in England

  • An engagement webinar hosted by CPSS can be viewed HERE

Flu vaccination service

 

 

 

 

 

 

 

 

 

Community pharmacy has been providing flu vaccinations under a nationally commissioned service since September 2015.

Each year from September through to March the NHS runs a seasonal flu vaccination campaign aiming to vaccinate all patients who are at risk of developing more serious complications from the virus. 

Community pharmacists can vaccinate all people aged 50 years and over and people aged from 18 to 49 years of age in clinical risk groups. Community pharmacists can also vaccinate patients in their own homes and at long-stay residential care homes or other long-stay care facilities. For full list of eligable patients see the service specification below. 

Service specification Flu vaccination advanced service 2021/22 can be downloaded here.

PGD 2021/22 can be downloaded HERE

Please view our Flu pages in A-Z  HERE

More information can be found HERE

Hep C Testing Service

 

 

 

 

 

 

 

 

 

 

 

The Community Pharmacy Hepatitis C Antibody Testing Service was added to the Community Pharmacy Contractual Framework (CPCF) in 2020, commencing on 1st September. The introduction of this new Advanced Service was originally trailed in the 5-year CPCF agreement, but its planned introduction in April 2020 was delayed by five months because of the COVID-19 pandemic.

The service is focused on provision of point of care testing (POCT) for Hepatitis C (Hep C) antibodies to people who inject drugs (PWIDs), i.e. individuals who inject illicit drugs, e.g. steroids or heroin, but who haven’t yet moved to the point of accepting treatment for their substance use. Where people test positive for Hep C antibodies, they will be referred for a confirmatory test and treatment, where appropriate. 

Local useful information to provide the service can be found here.

For Surrey Pharmacies

For Sussex Pharmacies

Service specification can be downloaded HERE

More information on PSNC website HERE

Hypertension case-finding service

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Hypertension case-finding service has been commissioned as an Advanced service from 1st October 2021.

Work is still underway to finalise the service specification and other details; additional information, guidance and support materials will be made available to contractors as soon as possible.

The service will have two stages – the first is identifying people at risk of hypertension and offering them blood pressure monitoring (a ‘clinic check’).

The second stage, where clinically indicated, is offering 24 hour ambulatory blood pressure monitoring (ABPM). The blood pressure test results will then be shared with the patient’s GP to inform a potential diagnosis of hypertension.

The following fees have been agreed:

  • A set-up fee of £440;
  • A fee for each clinic check of £15; and
  • A fee for each ambulatory monitoring of £45.

In addition, the following incentive fees across Years 3, 4 and 5 of the CPCF 5-year agreement, will be available. Pharmacies must reach a threshold of ABPM activity to trigger the payment of the incentive fee.

  • An incentive fee of £1,000 will be available if 5 ABPM intervention are provided in 2021/22;
  • Followed by a payment of £400 in the subsequent years if the pharmacy reaches the thresholds for those years (15 ABPM interventions will be required in 2022/23 and 20 in 2023/24).

New medicine service (NMS)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The service provides support for people with long-term conditions newly prescribed a medicine to help improve medicines adherence; it is focused on specific patient groups and conditions.

Changes to the NMS service were agreed as part of the Year 3 5-year CPCF deal, with these implemented from 1st September 2021: 

  • Additional eligible conditions were added to the service – see the Patients eligible for the service and the NMS medicines list section below for the details. The rationale for selection of the conditions mirrors that used in identifying the original four therapy areas/conditions: firstly, that there is evidence from research that adherence to medication in this condition could be improved and secondly that reviews of available research suggest these are areas where community pharmacists are best able to support improvements in patient understanding and adherence to treatments; 
  • Contractors who have received an exemption from the requirement to have a consultation room (due to their premises size) from their regional NHSE&I team, can provide the service remotely or at the patient’s home. All other contractors providing the service can similarly continue to provide the service remotely, where appropriate, and in the patient’s home.
  • The cap on the number of NMS which can be provided by contractors increased from 0.5 percent to one percent of monthly prescription volume and additional bandings were included; 
  • The service can be offered to support parents/guardians/carers of children and adults newly prescribed eligible medicines who could benefit from the service, but where the patient is not able to provide informed consent; and 
  • A catch-up NMS was introduced for 2021/22 to provide support to patients who were prescribed a new medicine during the COVID-19 pandemic but who did not receive the NMS at that time. This catch-up NMS also supports patients identified through the Pharmacy Quality Scheme who have missed inhaler technique checks to optimise use of their inhaler. 

Supporting documents and information can be found on PSNC website here and on NHSBSA here.

Service specification can be downloaded here.

Expanded NMS drug list can be downloaded here (excel file)

Expanded NMS BNF categories can be download here (excel file)

Stop smoking Advanced Service

 

 

 

 

 

 

 

 

 

Stop Smoking service for people referred to pharmacies by a hospital, which will be commissioned as an Advanced service from January 2022.

Work is still underway to finalise the service specification and other details; additional information, guidance and support materials will be made available to contractors in due course.

 

This service enables NHS trusts to refer patients discharged from hospital to a community pharmacy of their choice to continue their smoking cessation care pathway, including providing medication and behavioural support as required, in line with the NHS Long Term Plan care model for tobacco addiction.

The following fees have been agreed:

  • A set-up fee of £1,000;
  • A fee for the first consultation of £30;
  • A fee for each interim patient consultation of £10; and
  • A fee last consultation of £40.

Pandemic Delivery Service

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

From 16th March 2021 to 23:59 on 31st March 2022, people who have been notified of the need to self-isolate by NHS Test and Trace are able to access support for the delivery of their prescriptions from contractors.

This means all pharmacies (excluding distance selling pharmacies) are required to ensure those people who have been notified by NHS Test and Trace to self-isolate can receive their prescription medicines and appliances by home delivery during the ten-day self-isolation period, if they are unable to arrange for medicines to be picked up.

This service is only available to people during their ten-day* self-isolation period and who can provide their NHS Test and Trace Account ID when requesting the service (people are provided a unique NHS Test and Trace Account ID, which is an 8-character mix of letters and numbers, when they are contacted by NHS Test and Trace).

A record of the NHS Test and Trace Account ID reference number must be made and retained as part of the contractor’s delivery record.

The service specification sets out the requirements the contractor must comply with, including keeping records of the eligible patients to whom a delivery was made under this service and the date of the delivery.

Contractors can claim, via the Manage Your Service (MYS) portala payment of £6 (including VAT) per delivery, as part of the normal end of month process.

When the NHSBSA make the payments for provision of the Advanced service, they will be separately itemised on the FP34 Schedule of Payments, listed as ‘Additional advance payment’ under the section titled ‘Summary of Payment Amounts’.

More information can be found here.


For more information